Medtronic plc Proceeds from Sale of Equity Method Investments
Medtronic plc (MDT) reported Proceeds from Sale of Equity Method Investments of $24.00 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfEquityMethodInvestments · last filed 2026-09-03
- Medtronic plc proceeds from sale of equity method investments for the quarter ending 2026-07-31 was $24.00M, a 41.18% increase year-over-year.
- Medtronic plc proceeds from sale of equity method investments for the quarter ending 2026-04-24 was $86.00M, a 54.26% decline year-over-year.
- Medtronic plc proceeds from sale of equity method investments for the quarter ending 2026-01-23 was $21.00M, a 22.22% decline year-over-year.
- Medtronic plc proceeds from sale of equity method investments for the quarter ending 2025-07-25 was $17.00M.
- Medtronic plc proceeds from sale of equity method investments for fiscal 2026 was $139.00M, a 54.87% decline from fiscal 2025.
- Medtronic plc proceeds from sale of equity method investments for fiscal 2025 was $308.00M.
| Period end | Proceeds from Sale of Equity Method Investments 1 month | Proceeds from Sale of Equity Method Investments 3 month | Proceeds from Sale of Equity Method Investments 6 month | Proceeds from Sale of Equity Method Investments 9 month | Proceeds from Sale of Equity Method Investments 12 month |
|---|---|---|---|---|---|
| 2026-07-31 | $24.00M 10-Q · filed 2026-09-03 | $110.00M derived: sum of 2 quarters · filed 2026-09-03 | $131.00M derived: sum of 3 quarters · filed 2026-09-03 | ||
| 2026-04-24 | $86.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $107.00M derived: sum of 2 quarters · filed 2026-06-18 | $139.00M 10-K · filed 2026-06-18 | ||
| 2026-01-23 | $21.00M 10-Q · filed 2026-02-24 | $53.00M 10-Q · filed 2026-02-24 | |||
| 2025-07-25 | $17.00M 10-Q · filed 2026-09-03 | $205.00M derived: sum of 2 quarters · filed 2026-09-03 | $232.00M derived: sum of 3 quarters · filed 2026-09-03 | ||
| 2025-04-25 | $188.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $215.00M derived: sum of 2 quarters · filed 2026-06-18 | $308.00M 10-K · filed 2026-06-18 | ||
| 2025-01-24 | $27.00M 10-Q · filed 2026-02-24 | $120.00M 10-Q · filed 2026-02-24 | |||
| 2018-04-27 | $72.00M 10-K · filed 2018-06-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B |